The research agenda behind Neurospan.
Mechanisms, open questions, and research directions shaping Neurospan's view of neurodegeneration.
Protein aggregation control
Track how amyloid, tau, alpha-synuclein, TDP-43, and related aggregation failures disrupt neurons across diseases.
- Map where aggregation is upstream versus downstream.
- Clarify which intervention strategies actually aim to prevent buildup versus clear it.
- Connect this lane back into Discover explainers and Key Targets.
Mitochondrial resilience and energy metabolism
Follow the work on cellular energy failure, oxidative stress, and why neurons are especially vulnerable to metabolic breakdown.
- Track mechanism-first interventions rather than vague anti-ageing claims.
- Identify crossover between mitochondrial dysfunction and inflammation.
- Keep prevention questions tied to real mechanisms.
Neuroinflammation and microglial state control
Keep a mechanism-first view on how microglia, inflammatory signalling, and immune misfires can accelerate neuronal damage.
- Separate acute immune defence from chronic damaging inflammation.
- Track where inflammation is causal, secondary, or self-reinforcing.
- Identify the most legible interventions and open questions.
Cleanup systems, lysosomes, and autophagy
Follow the brain's waste-disposal and protein-recycling machinery, and what happens when those systems degrade.
- Clarify autophagy, lysosomal function, and proteasome activity.
- Track therapies that enhance natural cleanup rather than just suppress symptoms.
- Connect clearance failure to resilience across diseases.
Biomarkers and earlier detection
Make earlier measurement more legible, from fluid biomarkers to imaging, digital markers, and risk-tracking logic.
- Translate biomarker progress into clearer public understanding.
- Connect detection with realistic intervention timing.
- Keep measurement grounded to what would change decisions.
Clinical trial interpretation
Use the pipeline monitor to track which programmes matter, what changed, and how the treatment landscape is shifting.
- Pull signal from trial movement instead of hype cycles.
- Track status, phase, recruitment, and catalysts.
- Keep it connected to real source links and programme context.
Prevention architecture
Build clearer thinking around how monitoring, mechanistic intervention, and risk reduction might fit together before severe decline begins.
- Treat prevention as a systems problem, not a supplements list.
- Connect mechanisms to real monitoring strategies.
- Clarify what long-term brain protection could actually require.
Neurodegeneration literacy infrastructure
Make the science easier to follow without flattening the uncertainties or the stakes.
- Turn insights into Discover episodes, essays, and tools.
- Reduce the gap between raw literature and public understanding.
- Use communication to attract better contributors into the field.
Explore related pages
Disease hubs, key targets, Discover, and ways to contribute.
Disease-specific pipeline views for Alzheimer's, Parkinson's, ALS, and more.